Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy-Reference-Cited by-同舟云学术

Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy

Published:2013-10-16 Issue:12 Volume:48 Page:1394-1398
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Farkas Klaudia,Lakatos Péter László,Nagy Ferenc,Szepes Zoltán,Miheller Pál,Papp Mária,Palatka Károly,Bálint Anita,Bor Renáta,Wittmann Tibor,Molnár Tamás

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

http://www.tandfonline.com/doi/pdf/10.3109/00365521.2013.845906

Reference6 articles.

1. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response?

2. Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy

3. Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study

4. Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

5. Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulators after the discontinuation of anti‐tumor necrosis factor‐alpha antibody treatment and relapse in ulcerative colitis: A multicenter cohort study;Journal of Gastroenterology and Hepatology;2023-10-12

2. Complete Endoscopic Healing Is Associated With Lower Relapse Risk After Anti-TNF Withdrawal in Inflammatory Bowel Disease;Clinical Gastroenterology and Hepatology;2023-03

3. ECCO Topical Review on Biological Treatment Cycles in Crohn’s Disease;Journal of Crohn's and Colitis;2023-01-10

4. Long-term clinical outcomes after the discontinuation of anti-TNF agents in patients with inflammatory bowel disease: a meta-analysis;Revista Española de Enfermedades Digestivas;2023

5. How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study;World Journal of Gastroenterology;2022-07-28